In triple-negative breast cancer cells, OME inhibits invasion in vitro and lung metastasis in vivo through a genomic pathway involving downregulation of the G-protein coupled receptor CXCR4, which is involved in tumor promotion and metastasis [44]. The gene discussed is CXCR4; the disease is neoplasm.